Multiple myeloma: challenges and opportunities.
Joshua
Douglas
D
Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
Brown
Ross
R
Ho
P Joy
PJ
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology; D013792:Thalidomide / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013792:Thalidomide